Amoxici1

Details About Generic Salt ::  Amoxici1

Main Medicine Class:: Aminopenicillin   

(uh-MOX-ih-sil-in/CLAV-you-lah-nate poe-TASS-ee-uhm)
Augmentin
Tablets: 250 mg amoxicillin/125 mg clavulanic acid, 500 mg amoxicillin/125 mg clavulanic acid, 875 mg amoxicillin/125 mg clavulanic acid
Chewable tablets: 125 mg amoxicillin/31.25 mg clavulanic acid, 200 mg amoxicillin/28.5 mg clavulanic acid, 250 mg amoxicillin/62.5 mg clavulanic acid, 400 mg amoxicillin/57 mg clavulanic acid
Powder for oral suspension: 125 mg amoxicillin/31.25 mg clavulanic acid/5 mL, 200 mg amoxicillin/28.5 mg clavulanic acid/5 mL, 250 mg amoxicillin/62.5 mg clavulanic acid/5 mL, 400 mg amoxicillin/57 mg clavulanic acid/5 mL
Augmentin ES-600
Powder for oral suspension: 600 mg amoxicillin (as trihydrate) and 42.9 mg clavulanic acid/5 mL (as the potassium salt).
Class: Aminopenicillin

 

Drugs Class ::

 Action Amoxicillin inhibits bacterial cell wall mucopeptide synthesis. Clavulanic acid inactivates a wide range of beta-lactam enzymes found in bacteria resistant to penicillins and cephalosporins.

Indications for Drugs ::

 Indications Treatment of infections caused by susceptible strains of microorganisms.

Drug Dose ::

 Route/Dosage

Augmentin

Strength listed below is based on amoxicillin content.

ADULTS AND CHILDREN OVER 12 YR: PO One 500 mg tablet q 12 hr or one 250 mg tablet q 8 hr (500 and 250 mg tablets contain the same amount of clavulanate. Thus two 250 mg tablets are not equivalent to one 500 mg tablet.)

Severe Infections

PO 500 mg q 8 hr; 875 mg q 12 hr.

CHILDREN UNDER 3 MO: PO Elimination impaired in children under 3 mo. 30 mg/kg/day divided q 12 hr. CHILDREN OVER 3 YR: PO For otitis media, sinusitis, lower respiratory tract infections, severe infections, 45 mg/kg/day if given q 12 hr; 40 mg/kg/day if given q 8 hr. LESS SEVERE INFECTIONS FOR CHILDREN: PO 25 mg/kg/day if given q 12 hr; 20 mg/kg/day if given q 8 hr.

Augmentin ES-600

Augmentin ES-600 (5 mL) does not contain the same amount of clavulanic acid as any of the other Augmentin suspensions (5 mL). Therefore, Augmentin ES-600 and Augmentin are not interchangeable. The dose listed below is based on the amoxicillin component. CHILDREN 3 MO AND OLDER: PO 90 mg/kg/day divided q 12 hr for 10 days.

Contraindication ::

 Contraindications History of amoxicillin/clavulanate-associated cholestatic jaundice or liver disease.

Drug Precautions ::

 Precautions

Pregnancy: Category B. Children: Safety and efficacy of Augmentin ES-600 in children weighing 40 kg or more not established. Adults: Safety and efficacy of Augmentin ES-600 not established. Lactation: Secreted into breast milk. Mononucleosis patients: Increased risk of skin rash. Use not recommended. Phenylalanine: Contains phenylalanine. 200 and 400 mg chewable tablets, 200 mg/5 mL and 400 mg/5 mL only. Renal: Dose reduction or q 12 hr recommended with severe impairment. Hepatic: Use with caution.

Drug Side Effects ::

 Adverse Reactions

CNS: Dizziness; fatigue; insomnia; reversible hyperactivity. DERM: Erythema multiforme; maculopapular to exfoliative dermatitis; skin rashes; vesicular eruptions; urticaria. EENT: Abnormal taste sensation; black “hairy” tongue; glossitis; itchy eyes; laryngeal edema; laryngospasm; sore or dry mouth or tongue; stomatitis. GI: Abdominal pain or cramps; anorexia; diarrhea or bloody diarrhea; enterocolitis; epigastric distress; flatulence; gastritis; nausea; pseudomembranous colitis; rectal bleeding; vomiting. GU: Interstitial nephritis (eg, oliguria, proteinuria, hematuria, hyaline casts, pyuria); nephropathy; vaginitis. HEMA: Agranulocytosis; anemia; basophils; bone marrow depression; eosinophilia; granulocytopenia; hemolytic anemia; increased monocytes; increased or decreased lymphocyte count; leukopenia; neutropenia; platelets; prolonged bleeding and prothrombin time; reduced hemoglobin or hematocrit; thrombocytopenia; thrombocytopenic purpura. HEPA: Cholestatic jaundice; transient hepatitis. META: Albumin; elevated serum alkaline phosphatase and hypernatremia; reduced serum potassium; total proteins and uric acid. OTHER: Hyperthermia; superinfection.

Drug Mode of Action ::  

 Action Amoxicillin inhibits bacterial cell wall mucopeptide synthesis. Clavulanic acid inactivates a wide range of beta-lactam enzymes found in bacteria resistant to penicillins and cephalosporins.

Drug Interactions ::

 Interactions

Allopurinol: May increase incidence of rash. Contraceptives, oral: May reduce effectiveness of oral contraceptives. Probenecid: May increase and prolong blood levels of amoxicillin. Tetracyclines: May reduce antibacterial effectiveness of amoxicillin.

Drug Assesment ::

 Precautions

Pregnancy: Category B. Children: Safety and efficacy of Augmentin ES-600 in children weighing 40 kg or more not established. Adults: Safety and efficacy of Augmentin ES-600 not established. Lactation: Secreted into breast milk. Mononucleosis patients: Increased risk of skin rash. Use not recommended. Phenylalanine: Contains phenylalanine. 200 and 400 mg chewable tablets, 200 mg/5 mL and 400 mg/5 mL only. Renal: Dose reduction or q 12 hr recommended with severe impairment. Hepatic: Use with caution.

Drug Storage/Management ::

 Precautions

Pregnancy: Category B. Children: Safety and efficacy of Augmentin ES-600 in children weighing 40 kg or more not established. Adults: Safety and efficacy of Augmentin ES-600 not established. Lactation: Secreted into breast milk. Mononucleosis patients: Increased risk of skin rash. Use not recommended. Phenylalanine: Contains phenylalanine. 200 and 400 mg chewable tablets, 200 mg/5 mL and 400 mg/5 mL only. Renal: Dose reduction or q 12 hr recommended with severe impairment. Hepatic: Use with caution.

Drug Notes ::

 Precautions

Pregnancy: Category B. Children: Safety and efficacy of Augmentin ES-600 in children weighing 40 kg or more not established. Adults: Safety and efficacy of Augmentin ES-600 not established. Lactation: Secreted into breast milk. Mononucleosis patients: Increased risk of skin rash. Use not recommended. Phenylalanine: Contains phenylalanine. 200 and 400 mg chewable tablets, 200 mg/5 mL and 400 mg/5 mL only. Renal: Dose reduction or q 12 hr recommended with severe impairment. Hepatic: Use with caution.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

Leave a comment

Your email address will not be published. Required fields are marked *

royalmpo Royalmpo Royalmpo royalmpo royalmpo royalmpo royalmpo https://malangtoday.id/ https://guyonanbola.com/ renunganhariankatolik.web.id royalmpo royalmpo royalmpo dewaslot168 ri188 https://hayzlett.com/c-suite-network/ kingslot jkt88 mpodewa https://going-natural.com/the-story-behind-the-mutilated-scalp-video/ royalmpo/ pisang88/ langkahcurang/ mpohoki/ mpocuan/ royalmpo/ mporoyal/ asiaslot/ rajaslot138/ royalmpo https://hayzlett.com/news/ rajaslot88/ Analisis Scatter Hitam MahjongWays RTP Terukur Kemenangan Puluhan Grid Fase Awal Mahjong Pola Perilaku Pemain Harian Prediksi Strategi Game Terbaik RTP Strategi Target Kemenangan Tekanan Meja Live Kasino Slot Digital Hiburan Ringan Slot Online Tanpa Target Mengelola Mood Pemain Slot https://going-natural.com/my-braid-locs/ https://going-natural.com/kellen-marcus/ narutoslot bangslot royalmpo royalmpo macanasia bosslot slotking gacorway
Strategi Analitik Platform Game Dalam Mengelola Variasi Pola Permainan Online Di Era Windows 12 Pendekatan Data Driven Dalam Memahami Ritme Sistem Permainan Digital Pada Ekosistem Android Modern Studi Dinamika Platform Gaming Melalui Distribusi Kombinasi Simbol Di Tengah Popularitas Xbox Game Pass Analisis Strategi Modern Dalam Mengelola Volatilitas Sistem Permainan Digital Saat Tren Nintendo Kembali Naik Framework Pengolahan Data Gaming Untuk Menjaga Stabilitas Pola Permainan Dalam Era Gemini AI Tools Teori Permainan Mahjong Ways Dalam Analisa Intensitas Sistem RTP Online Pada Perangkat Smartphone Modern Pendekatan Sistematis Dalam Menganalisis Pola Permainan Pada Ekosistem Gaming Setelah Discord Down Model Evaluasi Strategi Platform Game Melalui Observasi Pergerakan Algoritma Setelah Update iOS 26.3.1 Strategi Adaptif Dalam Mengelola Ritme Permainan Pada Platform Digital Dengan Dukungan Windows 12 Pendekatan Data Analitik Untuk Mengidentifikasi Pola Sistem Permainan Mobile Pada Samsung Galaxy S26 Ultra